Back to top
more

EUROFINS SCIENT (ERFSF)

(Delayed Data from OTC)

$60.00 USD

60.00
1,288

-0.01 (-0.02%)

Updated Apr 26, 2024 01:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?

EUROFINS SCIENT (ERFSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways

Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways

Urmimala Biswas headshot

5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges

Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Services industry. AVTR, ERFSF, GDRX, AMEH and CMPS are poised to gain.

What Makes EUROFINS SCIENT (ERFSF) a Good Fit for "Trend Investing"

EUROFINS SCIENT (ERFSF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

EUROFINS SCIENT (ERFSF) Moves to Strong Buy: Rationale Behind the Upgrade

EUROFINS SCIENT (ERFSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for March 25th

OMP, PBFX, WRLD, ERFSF, and UBAB have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2021.

ERFSF or HQY: Which Is the Better Value Stock Right Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

Sapna Bagaria headshot

5 Healthcare Stocks to Keep the Winning Streak Alive in 2020

Increasing incidence of chronic diseases, aging U.S. population, innovation and consolidation will drive the healthcare industry's growth in 2020.

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Is EUROFINS SCIENT (ERFSF) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF or HQY: Which Is the Better Value Stock Right Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF vs. ICLR: Which Stock Should Value Investors Buy Now?

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

ERFSF vs. ICLR: Which Stock Is the Better Value Option?